NO178718C - Preparat for anvendelse in vitro, udödelig, transformert cellelinje og humant, monoklonalt antistoff, samt sett eller utstyr for anvendelse ved påvisning in vitro av tilstedeværelse av Pseudomonas aeruginosa - Google Patents

Preparat for anvendelse in vitro, udödelig, transformert cellelinje og humant, monoklonalt antistoff, samt sett eller utstyr for anvendelse ved påvisning in vitro av tilstedeværelse av Pseudomonas aeruginosa

Info

Publication number
NO178718C
NO178718C NO864971A NO864971A NO178718C NO 178718 C NO178718 C NO 178718C NO 864971 A NO864971 A NO 864971A NO 864971 A NO864971 A NO 864971A NO 178718 C NO178718 C NO 178718C
Authority
NO
Norway
Prior art keywords
vitro
immortalized
kits
preparation
equipment
Prior art date
Application number
NO864971A
Other languages
English (en)
Norwegian (no)
Other versions
NO178718B (no
NO864971D0 (no
NO864971L (no
Inventor
Anthony W Siadak
Mae J Rosok
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of NO864971D0 publication Critical patent/NO864971D0/no
Publication of NO864971L publication Critical patent/NO864971L/no
Publication of NO178718B publication Critical patent/NO178718B/no
Publication of NO178718C publication Critical patent/NO178718C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO864971A 1985-12-10 1986-12-10 Preparat for anvendelse in vitro, udödelig, transformert cellelinje og humant, monoklonalt antistoff, samt sett eller utstyr for anvendelse ved påvisning in vitro av tilstedeværelse av Pseudomonas aeruginosa NO178718C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80739485A 1985-12-10 1985-12-10
US93117986A 1986-11-24 1986-11-24

Publications (4)

Publication Number Publication Date
NO864971D0 NO864971D0 (no) 1986-12-10
NO864971L NO864971L (no) 1987-06-11
NO178718B NO178718B (no) 1996-02-12
NO178718C true NO178718C (no) 1996-05-22

Family

ID=27123006

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864971A NO178718C (no) 1985-12-10 1986-12-10 Preparat for anvendelse in vitro, udödelig, transformert cellelinje og humant, monoklonalt antistoff, samt sett eller utstyr for anvendelse ved påvisning in vitro av tilstedeværelse av Pseudomonas aeruginosa

Country Status (21)

Country Link
US (4) US5378812A (nl)
JP (1) JPH07116237B2 (nl)
KR (1) KR910008361B1 (nl)
CN (1) CN86108380A (nl)
AT (1) AT400441B (nl)
BE (1) BE905890A (nl)
CH (1) CH677362A5 (nl)
DE (1) DE3642095C2 (nl)
DK (1) DK594586A (nl)
FI (1) FI86377C (nl)
FR (1) FR2593826B1 (nl)
GB (1) GB2185266B (nl)
HU (1) HUT41836A (nl)
IE (1) IE59741B1 (nl)
IT (1) IT1199735B (nl)
LU (1) LU86711A1 (nl)
NL (1) NL8603132A (nl)
NO (1) NO178718C (nl)
NZ (1) NZ218499A (nl)
PT (1) PT83894B (nl)
SE (1) SE468831B (nl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
AU615162B2 (en) * 1986-07-03 1991-09-26 Genetic Systems Corporation Monoclonal antibodies to pseudomonas aeruginosa flagella
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies
JP2725041B2 (ja) * 1986-12-15 1998-03-09 三井東圧化学株式会社 ヒトモノクローナル抗体とそれを有効成分とする感染症の予防、治療剤
US5521085A (en) * 1986-12-15 1996-05-28 Mitsui Toatsu Chemicals, Inc. Transformed cell lines producing human monoclonal antibodies specific for Pseudomonas aeruginosa serotypes
JPH01197500A (ja) * 1988-01-29 1989-08-09 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
GB2218703B (en) * 1988-05-10 1992-10-28 Sumitomo Chemical Co Human monoclonal antibody to p.aeruginosa: its production and use
CA1341375C (en) * 1988-10-12 2002-07-09 Baxter International Inc. Compositions and methods for the treatment and prevention of gram-negative bacterial infections
EP0382031A3 (en) * 1989-02-10 1991-06-26 Miles Inc. Monoclonal antibodies in immune serum globulin
US4994269A (en) * 1989-03-17 1991-02-19 Miles Inc. Topical use of antibodies for prevention or treatment of pseudomonas infections
AU619672B2 (en) * 1989-03-20 1992-01-30 Mitsui Toatsu Chemicals Inc. Human monoclonal antibody reactive with pseudomonas aeruginosa, cell which produces the antibody, method of production, and pharmaceutical preparation
JPH02283294A (ja) * 1989-04-24 1990-11-20 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
AU5675790A (en) * 1989-05-09 1990-11-29 Cetus Corporation Human monoclonal antibodies to sero-specific determinants of gram-negative bacteria
US5858728A (en) * 1991-03-13 1999-01-12 Common Services Agency Monoclonal antibody against LPS core
US20030096315A1 (en) 2000-05-03 2003-05-22 Sanders Mitchell C. Device for detecting bacterial contamination and method of use
EP1576181B1 (en) * 2002-01-31 2013-08-14 Systagenix Wound Management IP Co. BV. Method for detecting pathogenic bacteria in wounds
WO2003102142A2 (en) * 2002-05-29 2003-12-11 Henry M. Jackson Foundation For The Advancement Of Military Medicine Inc. Arrays identifying genomic and proteomic biomarkers for cystic fibrosis
JP5271475B2 (ja) 2002-11-26 2013-08-21 ザ ユニヴァーシティー オヴ シカゴ 微生物媒介上皮疾患の予防及び治療のための材料並びに方法
CA2514938A1 (en) * 2003-01-31 2004-10-14 Ethicon, Inc. Method for detecting escherichia coli
ATE382862T1 (de) 2003-11-03 2008-01-15 Ethicon Inc Verfahren, peptide und biosensoren mit eignung zum nachweis eines breiten spektrums von bakterien
EP1690875A1 (en) * 2005-02-14 2006-08-16 Kenta Biotech AG Human monoclonal antibody specific for lipopolysaccharides (LPS) of the pseudomonas aeruginosa IATS O11 serotype
US8788049B2 (en) * 2006-05-01 2014-07-22 Bioness Neuromodulation Ltd. Functional electrical stimulation systems
WO2010091189A1 (en) * 2009-02-04 2010-08-12 Kalobios Pharmaceuticals, Inc. Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
CA2790232A1 (en) * 2010-02-18 2011-08-25 Meiji Seika Pharma Co., Ltd. Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH652145A5 (de) * 1982-01-22 1985-10-31 Sandoz Ag Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes
JPS59137497A (ja) * 1983-01-20 1984-08-07 ザ・リ−ジエンツ・オブ・ザ・ユニバ−シテイ・オブ・カリフオルニア 抗原特異的免疫グロブリン生産性ヒト／ヒトハイブリド−マ及びその生産する抗体
JPS58216125A (ja) * 1982-06-09 1983-12-15 Asahi Chem Ind Co Ltd ヒト抗体の産生方法
JPS5929622A (ja) * 1982-08-10 1984-02-16 Meiji Seika Kaisha Ltd モノクロ−ナル抗体、その製造法およびその用途
AU585200B2 (en) * 1983-05-06 1989-06-15 Velos Group Monoclonal antibodies reactive with endotoxin core
US4587121A (en) * 1983-06-14 1986-05-06 Miles Laboratories, Inc. High titer Pseudomonas immune serum globulin
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
WO1985002685A1 (en) * 1983-12-12 1985-06-20 Meru, Inc. Method and materials for the identification of lipopolysaccharide producing microorganisms
US4683196A (en) * 1983-12-12 1987-07-28 Meru, Inc. Method and materials for the identification of lipopolysaccharide producing microorganisms
JP2565303B2 (ja) * 1984-05-25 1996-12-18 三井東圧化学株式会社 緑膿菌感染症の予防治療剤
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
JPS60248625A (ja) * 1984-05-25 1985-12-09 Mitsui Toatsu Chem Inc 抗緑膿菌モノクロ−ナル抗体、その製法ならびに用途
DE3426903A1 (de) * 1984-07-20 1986-01-23 Biotest Pharma GmbH, 6000 Frankfurt Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
AU597877B2 (en) * 1984-12-26 1990-06-14 Teijin Limited Anti-pseudomonas aeruginosa human monoclonal antibody
US4677070A (en) * 1985-04-26 1987-06-30 Cetus Corporation Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
JPS6229175A (ja) * 1985-07-29 1987-02-07 Nippon Telegr & Teleph Corp <Ntt> 電界効果型トランジスタの製造方法
EP0211352B1 (en) * 1985-08-01 1994-03-16 Miles Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4777136A (en) * 1985-09-27 1988-10-11 The Regents Of The University Of California Monoclonal antibody reactive with Pseudomonas Aeruginosa
US4970070A (en) * 1986-02-07 1990-11-13 Genetic Systems Corporation Protective monoclonal antibody compositions for infections due to group B streptococcus
AU615162B2 (en) * 1986-07-03 1991-09-26 Genetic Systems Corporation Monoclonal antibodies to pseudomonas aeruginosa flagella
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies

Also Published As

Publication number Publication date
SE468831B (sv) 1993-03-29
CH677362A5 (nl) 1991-05-15
DE3642095C2 (de) 1998-10-01
NL8603132A (nl) 1987-07-01
PT83894B (pt) 1989-07-31
KR910008361B1 (ko) 1991-10-12
IT8622630A0 (it) 1986-12-10
AT400441B (de) 1995-12-27
NO178718B (no) 1996-02-12
HUT41836A (en) 1987-05-28
FI865027A0 (fi) 1986-12-10
FI86377C (fi) 1992-08-25
FR2593826A1 (fr) 1987-08-07
NZ218499A (en) 1990-04-26
GB8629540D0 (en) 1987-01-21
DK594586D0 (da) 1986-12-10
KR870005648A (ko) 1987-07-06
SE8605295D0 (sv) 1986-12-10
US5378812A (en) 1995-01-03
JPS62187417A (ja) 1987-08-15
ATA328286A (de) 1995-05-15
BE905890A (fr) 1987-06-10
SE8605295L (sv) 1987-06-11
CN86108380A (zh) 1987-10-28
NO864971D0 (no) 1986-12-10
DK594586A (da) 1987-06-11
FI865027A (fi) 1987-06-11
GB2185266B (en) 1990-09-05
LU86711A1 (fr) 1988-07-14
US5627067A (en) 1997-05-06
IT1199735B (it) 1988-12-30
FR2593826B1 (fr) 1990-11-16
IE59741B1 (en) 1994-03-23
GB2185266A (en) 1987-07-15
JPH07116237B2 (ja) 1995-12-13
US5662905A (en) 1997-09-02
DE3642095A1 (de) 1987-07-02
PT83894A (en) 1987-01-01
IE863230L (en) 1987-06-10
US5628996A (en) 1997-05-13
FI86377B (fi) 1992-05-15
NO864971L (no) 1987-06-11

Similar Documents

Publication Publication Date Title
NO178718C (no) Preparat for anvendelse in vitro, udödelig, transformert cellelinje og humant, monoklonalt antistoff, samt sett eller utstyr for anvendelse ved påvisning in vitro av tilstedeværelse av Pseudomonas aeruginosa
AU7566991A (en) Monoclonal antibody and immunoconjugates for the treatment and detection of b cell disorders
IT1225944B (it) Saggi immunometrici e di inibizione con l&#39;impiego di anticorpi monoclonici
IT8823166A0 (it) Procedimento e dispositivo per l&#39;analisi quantitativa e differenziale in profondita&#39; di provini solidi con l&#39;impiego di due raggi ionici
DK425583D0 (da) Fremgangsmade til fremstilling af 4&#39;-demethyl-epipodophyllotoxin-beta-d-ethylidenglycocid og acylderivater deraf samt mellemprodukt til brug ved fremgangsmaden
BR8202492A (pt) Dispositivo para analises imunologicas conjunto e uso do dispositivo ou do conjunto
AU5443286A (en) Test kit for determining the presence of organic materials and method of utilizing same
NO165598C (no) Fremgangsmaate for ekspresjon av hepatitt b overflateantigen i cellekultur samt ekspresjonsvektor.
FR2700010B1 (fr) Méthode et dispositif pour tester la réactivité de cellules à l&#39;égard de produits.
IT1119640B (it) Procedimento e dispositivo per la fabbricazione di cerniere lampo
DK52483A (da) Immunoanalytisk fremgangsmaade til bestemmelse af antigen-koncentra tioner i oploesning, samt materialer og udstyr til anvendelse ved remgangsmaaden
DE3477845D1 (en) Lewis blood group phenotype assay
DE2965570D1 (en) Method for the detection and/or determination of an antigen specific immunoglobulin, immuno-reagents to be used in said method and test kit for said determination
ATA425180A (de) Einrichtung zur metallspiegel-kryofixation sowie zur nachfolgenden kryopraeparation biologischer objekte
DK83187D0 (da) Fremgangsmaade til bestemmelse af mikroorganismekoncentrationer samt skaale til anvendelse ved fremgangsmaaden
BR8101452A (pt) Valvula de derivacao com placa corredica e processo de fabricacao da valvula de derivacao com placa corredica
IT7912545A0 (it) Metodo e dispositivo per la fabbricazione di recipienti di vetro
IT1127358B (it) Procedimento per la fabbricazione di contenitori aperti in particolare per uso sanitario
FR2601458B1 (fr) Anticorps monoclonaux contre les flagelles de pseudomonas aeruginosa
IT1129721B (it) Processo e reagente per la determinazione della perossidasi
DK478785D0 (da) Fremgangsmaade til maaling af signalkomposanternes egenskaber i evideosignal samt apparat til udoevelse af fremgangsmaaden
DK440485A (da) Indretning til overvaagning af i aabne eller halvaabne institutioner indtagne personer og armbaand til anvendelse sammen med denne indretning
DK563988D0 (da) Roer eller ledning og fremgangsmaade til fremstilling af et saadant roer eller en saadan ledning
IT1183809B (it) Procedimento per l&#39;analisi qualitativa e quantitativa di interferone epsilon
AU526550B2 (en) Amplifier and symmetrical bridge

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JUNE 2001